Profile data is unavailable for this security.
About the company
JZJ Chain Drugstore Corp is a China-based company principally engaged in chain retail business. The Company operates primarily through two segments. The Pharmaceutical Retail segment is mainly engaged in the retail of Chinese medicinal materials, health foods, personal care products, home health products and medical equipment. The Convenience Retail segment is mainly engaged in the sales of convenience products such as convenience foods and daily consumables. The Company is also engaged in the provision of professional services to pharmaceutical and convenience providers, as well as the provision of physical examination services to patients. The Company principally conducts its businesses in the domestic market.
- Revenue in CNY (TTM)9.32bn
- Net income in CNY236.80m
- Incorporated2004
- Employees16.65k
- LocationJZJ Chain Drugstore CorpComplex BuildingWanhong Jiayuan Fengyuan (Plot 5), LianmWanhong Road Intersection, Panlong DistrKUNMING 650224ChinaCHN
- Phone+86 87 165711920
- Fax+86 87 165711330
- Websitehttps://www.jzj.cn/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Charmacy Pharmaceutical Co Ltd | 4.48bn | 51.67m | 932.74m | 834.00 | 18.05 | 1.58 | 11.51 | 0.2084 | 0.5153 | 0.5153 | 44.63 | 5.90 | 1.47 | 5.49 | 4.76 | 5,800,294.00 | 1.70 | 1.79 | 8.48 | 7.99 | 6.91 | 6.16 | 1.15 | 1.24 | 0.7714 | 2.44 | 0.5882 | 37.09 | 5.47 | 2.27 | -43.25 | 2.48 | -16.01 | 0.0027 |
| Kimia Farma Tbk PT | 4.63bn | -783.52m | 1.58bn | 10.71k | -- | 0.6474 | -- | 0.3412 | -307.59 | -311.08 | 1,817.52 | 957.72 | 0.5415 | 2.78 | 4.36 | 882,472,800.00 | -11.90 | -1.82 | -23.42 | -3.22 | 24.05 | 35.14 | -21.98 | -3.08 | 0.4154 | -3.76 | 0.5702 | -- | 7.93 | 3.33 | -737.71 | -- | -9.87 | -- |
| Sipai Health Technology Co, Ltd | 4.63bn | -241.35m | 3.69bn | 3.25k | -- | 2.47 | -- | 0.7974 | -0.3309 | -0.3309 | 6.56 | 2.11 | 1.58 | 13.61 | 9.78 | 1,611,118.00 | -7.98 | -- | -13.82 | -- | 9.18 | -- | -5.05 | -- | 1.58 | -- | 0.0386 | -- | 14.39 | -- | 81.34 | -- | -- | -- |
| JZJ Chain Drugstore Corp | 9.32bn | 236.80m | 4.39bn | 16.65k | 18.27 | 1.58 | -- | 0.4708 | 1.53 | 1.53 | 60.20 | 17.72 | 0.9258 | 2.20 | 20.72 | 559,572.20 | 2.34 | 5.75 | 4.50 | 11.17 | 35.54 | 35.21 | 2.53 | 5.04 | 0.2655 | 2.88 | 0.6563 | 36.62 | 20.84 | 26.84 | 10.72 | 25.41 | 23.62 | -- |
| Genky DrugStores Co Ltd | 8.74bn | 300.44m | 4.42bn | 1.66k | 14.45 | 1.94 | 7.82 | 0.5060 | 212.46 | 212.46 | 6,180.37 | 1,582.20 | 1.67 | 6.47 | 43.31 | 113,208,300.00 | 5.76 | 4.94 | 8.65 | 7.86 | 20.41 | 20.67 | 3.44 | 2.98 | 0.4102 | 59.82 | 0.4195 | 8.24 | 9.35 | 12.21 | 32.75 | 18.58 | -0.5316 | 0.3968 |
| MedPlus Health Services Ltd | 5.13bn | 85.78m | 6.99bn | 21.00k | 81.70 | 4.99 | 24.03 | 1.36 | 8.37 | 8.37 | 500.31 | 136.89 | 1.97 | 3.55 | 447.43 | 2,855,699.00 | 3.29 | 2.68 | 4.02 | 3.48 | 22.66 | 21.14 | 1.67 | 1.38 | 0.6598 | 1.77 | 0.3863 | 0.00 | 23.42 | 19.87 | 31.57 | 40.59 | 31.14 | -- |
| Fangzhou Inc | 2.46bn | -860.54m | 8.26bn | 515.00 | -- | -- | -- | 3.36 | -0.6914 | -0.6914 | 1.98 | -1.60 | -- | -- | -- | 5,150,034.00 | -- | -- | -- | -- | 20.52 | -- | -34.94 | -- | 0.699 | -- | 30.75 | -- | 10.43 | -- | 48.66 | -- | -- | -- |
| Welcia Holdings Co Ltd | 57.49bn | 1.02bn | 18.77bn | 15.29k | 18.16 | 1.61 | 8.78 | 0.3265 | 106.05 | 106.05 | 5,982.48 | 1,194.41 | 2.11 | 6.31 | 17.08 | 80,917,640.00 | 3.67 | 5.76 | 6.63 | 10.23 | 30.23 | 30.81 | 1.74 | 2.51 | 0.6511 | 38.94 | 0.2343 | 23.97 | 6.38 | 9.33 | -2.14 | 8.71 | 2.59 | 10.12 |
| Dashenlin Pharmaceutical Group Co Ltd | 26.54bn | 850.26m | 19.10bn | 45.47k | 22.52 | 2.78 | -- | 0.7196 | 0.7445 | 0.7445 | 23.37 | 6.03 | 1.12 | 4.14 | 23.28 | 583,716.30 | 3.90 | 6.57 | 8.15 | 12.63 | 33.80 | 37.51 | 3.47 | 5.54 | 0.598 | 7.15 | 0.5981 | 45.67 | 15.45 | 22.59 | 12.63 | 17.02 | 26.51 | 6.85 |
Data as of Nov 14 2024. Currency figures normalised to JZJ Chain Drugstore Corp's reporting currency: Chinese Yuan Renminbi CNY
47.07%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Rongtong Fund Management Co., Ltd.as of 30 Jun 2024 | 12.83m | 16.82% |
| Guotai Asset Management Co., Ltd.as of 30 Jun 2024 | 9.72m | 12.75% |
| Essence Fund Co., Ltd.as of 30 Jun 2024 | 6.02m | 7.90% |
| ICBC Credit Suisse Asset Management Co., Ltd.as of 30 Jun 2024 | 2.69m | 3.53% |
| China Southern Asset Management Co., Ltd.as of 30 Jun 2024 | 1.68m | 2.21% |
| Penghua Fund Management Co., Ltd.as of 30 Jun 2024 | 1.38m | 1.81% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024 | 527.62k | 0.69% |
| Taikang Asset Management Co. Ltd.as of 30 Jun 2024 | 412.42k | 0.54% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 383.59k | 0.50% |
| Invesco Great Wall Fund Management Co. Ltd. (Invt Mgmt)as of 30 Jun 2024 | 237.72k | 0.31% |
More ▼
Data from 30 Jun 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
